Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neuroendocrine Tumors, UK NET Guidelines

Axel Walther

MD

🏢Bristol Cancer Institute🌐UK

Consultant Medical Oncologist

30
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Axel Walther at Bristol Cancer Institute is a UK NET specialist who has contributed to UK ENETS guidelines and clinical trial research in neuroendocrine tumors. His work on sunitinib in pancreatic NETs and his clinical leadership in establishing multidisciplinary NET teams reflect his commitment to improving NET care in the UK healthcare setting.

Share:

🧪Research Fields 研究领域

neuroendocrine tumors
UK NET guidelines
sunitinib
pancreatic NET
NET MDT

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Axel Walther 的研究动态

Follow Axel Walther's research updates

留下邮箱,当我们发布与 Axel Walther(Bristol Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment